Ascending Ramus Versus Chin Cortical Plates for Reconstruction of Atrophic Maxilla

August 13, 2018 updated by: ahmed yousri said zayed, Cairo University

Assessment of Mandibular Ascending Ramus Cortical Plates for Reconstruction of Atrophic Maxillary Ridges Versus Chin Cortical Plates(Randomized Clinical Tial)

Assessment of ascending ramus cortical plate for reconstruction of atrophic maxillary ridges versus chin cortical plates (Randomized clinical trial)

Study Overview

Detailed Description

Assessment of ascending ramus cortical plate for reconstruction of atrophic maxillary ridges versus chin cortical plates (Randomized clinical trial) To know what is better and more efficient chin or ascending ramus cortical plates.

Study Type

Interventional

Enrollment (Anticipated)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with atrophic maxilla with residual bone height from 3 to 4mm.
  • Both sexes

Exclusion Criteria:

  • Intraoral soft and hard tissue pathology.
  • Systemic condition that contraindicate implant basement.
  • Psychiatric problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ascending ramus group
  • Local anesthesia will be given to the patient
  • flap will be reflected to expose the facial wall of the maxilla then The ascending ramus is accessed.
  • A disc bur will be used to make a rectangular osteotomy
  • The block bone graft is removed from ascending ramus to recipient site the fixed by mini screws
  • Doner site flap is closed by using interrupted internal sutures.
  • after atrophic maxillary alveolar ridge augmentation,sub mucosal periosteal releasing cuts is done
  • Post-operative medications will be prescribed as follows: amoxicillin/clavulanic acid tablets 10mg/kg every 12 hours for 7 days, metronidazole 5 mg/kg every 8 hours for 7 days
Autogenous bone blocks from chin and ascending ramus are obtained and used for reconstruction of atrophic maxillary ridges
Active Comparator: Chin Group
  • Local anesthesia will be given to the patient
  • flap will be reflected to expose the facial wall of the maxilla then The chin is accessed.
  • A disc bur will be used to make a rectangular osteotomy
  • The block bone graft is removed from chin to recipient site the fixed by mini screws
  • Doner site flap is closed by using interrupted internal sutures
  • after atrophic maxillary alveolar ridge augmentation,submucosal periosteal releasing cuts is done
  • Post-operative medications will be prescribed as follows: amoxicillin/clavulanic acid tablets 10mg/kg every 12 hours for 7 days, metronidazole 5 mg/kg every 8 hours for 7days
Autogenous bone blocks from chin and ascending ramus are obtained and used for reconstruction of atrophic maxillary ridges

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
width and height of the bone gained by the procedure and the new measures from a physiologic vital structures e.g( nasal floor, maxillary sinus or even occlusal plan)
Time Frame: 6 months
new bone formation
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Histomorphometric analysis bone area percent
Time Frame: 6 months
Nature and quality of new bone histology
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ahmed Y Yousri, Bsd, Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Anticipated)

February 8, 2019

Study Completion (Anticipated)

April 9, 2019

Study Registration Dates

First Submitted

August 6, 2018

First Submitted That Met QC Criteria

August 13, 2018

First Posted (Actual)

August 14, 2018

Study Record Updates

Last Update Posted (Actual)

August 14, 2018

Last Update Submitted That Met QC Criteria

August 13, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Ahmed yousri

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

Websites and papers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe